Clinical Trial Update: Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Cingal to Triamcinolone Hexacetonide for knee osteoarthritis has completed and results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cingal
• Triamcinolone hexacetonide (triamcinolone hexacetonide)

Snippet

Sponsor: Anika Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-02-24